Heart drugs found not to cause increase in cancer risk

A meta-analysis of data has refuted an earlier claim linking drugs for reducing heart problems with an increase in cancer risk. The review claims to be based on better data from a larger number of people using the class of drugs whose safety had been called into question. The previous study was criticized for using data from short-term clinical trials, which researchers say would not be able to find a true link with cancer because of the delay in developing it after exposure to carcinogenic substances.

Read more at Journal of Hypertension

Expert Database

Want to write?

Write an article and join a growing community of more than 61,400 academics and researchers from 2,257 institutions.

Register now